Heron Therapeutics Inc (NASDAQ:HRTX)

During the Trading Day
13.02 -0.31 / -2.33%
As of 4:00pm ET
Day’s Change
During After-Hours   Switch to standard view »
13.02 0.00 / 0.00%
 
Volume: 322.00

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 4
2013
Quarter 1
2014
Quarter 2
2014
Quarter 3
2014
Revenue and IncomeNet Revenues0.000.000.000.00--
Depreciation And Amortization96.0K114.0K125.0K150.0K
 
 
 
 
 
 
Operating ExpensesGross Income-96.0K-114.0K-125.0K-150.0K
 
 
 
 
 
General Expenses13.7M17.2M18.7M18.8M
 
 
 
 
 
Research And Development9.6M11.8M14.4M14.7M
 
 
 
 
 
Total Operating Expenses13.8M17.3M18.8M19.0M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-13.8M-17.3M-18.8M-19.0M
 
 
 
 
 
Interest Expense On Debt212.0K216.0K220.0K241.0K
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-14.0M-17.5M-19.0M-19.2M
 
 
 
 
 
Net Income-14.0M-17.5M-19.0M-19.2M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS18.7M23.7M24.3M29.0M
 
 
 
 
 
Shares To Calculate EPS Diluted18.7M23.7M24.3M29.0M
 
 
 
 
 
 
Earnings Per ShareEPS-$0.75-$0.74-$0.78-$0.66
 
 
 
 
 
EPS Diluted-$0.75-$0.74-$0.78-$0.66
 
 
 
 
 
 

To view my watchlist

Not a member yet?

Sign up now for a free account